Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That’s like an 11 million credit card balance
I’m not saying a buyout. Have you seen the naked shirt plan that GNS has undertaken. Anything you issue to shareholders, triggers an accountability of shares on record date. It could simply be an option to buy advent shares in future if/when there was an IPO, at the IPO price.
I thought LP owned Advent. If so she could do such a deal.
They could just issue rights to shareholders to buy Advent. A transaction unlikely to ever be executed but that would trigger official share count.
Now they’ll have to open the hood and let Sarassin see all the crimes they have committed. Wouldn’t be surprised to see some outright firings in next few weeks.
Sarissa needs to add Marjac to legal team officially and reboot the case with support from company. The fact Amarin never supported EPADE II case is criminal.
Why is this article relevant? Is he invested in NWBO?
I keep getting white card as well
When approved it should trade no lower than nvcr which has a 9 plus billion market cap. That puts it at 6 bucks. You uplist then. soon after when revenues begin I would do a 30 for 1 reverse to reduce shares outstanding and make it harder to short, along with stock buyback plan and dual nft listing. As revenues come in further I’d instate a dividend to further thwart shorts.
The phase 3 trial they reference is DCVaxL. The other is some Florida based biotech. Perhaps the pill from FL will work well in combo with DCVaxL but it will take years of trials still.
The proactive GNS leadership has surely proved there are indeed rats in the kitchen.
This will be the only chance we get to get rid of this board and CEO. If Denner looses it will embolden them to continue GIA and trash the company into oblivion.
Glad I didn’t short NVCR on advise of NWBO cheerleaders. I actually almost bought some to bet on both horses. I don’t think they are mutually exclusive but they could work as a combo even.
If I read this correctly, NICE has begun appraisal as it believes drug will be approved during the process?
Have they submitted applications to an RA yet? They had two years to work on those. Journal is amazing and supportive but approvals are what’s necessary.
Good point
It’s sickening we get no coverage from main stream media and mRNA doing something similar and not yet ph3, not as effective and not peer reviewed gets the attention.
Not sure MRNA is cheaper to make a personalized vaccine. They would do a more general sequencing like our Direct I would think. Each one of DCVaxL is fully personalized. Was the melanoma study a specific personal vax for each patient or the same vax for everyone? I wasn’t sure.
Question is which approach is more effective, safer and cost effective to produce the personalized vaccines? MRNA or DCVax?
Shorts owe the dividend
They seem more brazen after lawsuit
Freeze your tumors without preservatives! The future is here.
I’d like to se the external control arm graphed against the two lines. Because both blow away the SOC. it’s then in the sequence that it works even better. Incredible stuff.
He has cost the lives of thousands. With no degree in medicine and they believe him over 70 qualified peer reviewers. Sad
Stop losses work both ways.
And since it’s OTC there are no options for shorts to hedge. Only buying
Constitutes libel plus stock manipulation.
They are trying to forestall 5/10 2.0 which leads to believe news are imminent.
Any other drug or company this would be front page huge news. There are billions of smokers that could benefit. Sure they’ll say what harmed the smokers was the placebo mineral oil and not the cigarettes.
Brain perhaps but not GBM
Bhatt tried for years without much help from Amarin. He w works for Big Pharma so who can blame him.
If it’s public property what’s the benefit?
Explain pls
Denner now can buy a few million shares extra to give himself a margin of error and lobby some retail
They didn’t count the votes at the ASM because they didn’t have enough fingers to count.
How come Amarin doesn’t make an immediate statement refuting these allegations. They suck
I thought it was obvious that V was effective. Isn’t that why the patents were yanked? This new info suggest that even now, there are doubters among us. They should reinstate the patents.
A placebo group will always get worst because of the underlying condition not being treated.